TrialsNest
Sign Up
Sponsors

Rescue planning for an under-enrolling clinical trial

A rescue-planning framework for under-enrolling clinical trials covering source quality, site execution, records blockers, visit burden, and sponsor decisions.

SponsorsUpdated 2026-06-135 min read

Under-enrollment should be diagnosed before teams increase advertising spend. The constraint may be source quality, site follow-up, records blockers, eligibility ambiguity, visit burden, or sponsor decision lag.

Published Updated By TrialsNest editorial
Editorial review

How this resource is reviewed

Reviewed by TrialsNest editorial review on . These guides are written for operational education and updated when workflow, buyer, or trust boundaries change.

Editorial lens

Sponsor operating note

under enrolling clinical trial rescue plan should help a sponsor decide what to ask next: source adjustment, site support, criteria clarification, stale-lead review, or reporting cadence. Counts matter most when they lead to an action.

Reading volume as quality

Source volume can hide weak reviewable fit, missing records, slow follow-up, or site capacity issues.

Letting reports become patient-detail workspaces

Sponsor visibility should stay focused on movement, blockers, source quality, close reasons, and next actions.

What to keep in view

A rescue plan should identify the constraint before changing the tactic.
Lead volume, reviewable source quality, site execution, records readiness, visit burden, and screen-failure reasons should be measured separately.
TrialsNest can show where patients stall so rescue planning is based on workflow evidence instead of abstract funnel counts.

Questions to answer before acting on this guide

What sponsor decision should under enrolling clinical trial rescue plan support?
Does the workflow separate source volume, site execution, blockers, and next actions?
Can the team explain what changed since the last enrollment or recruitment update?

Operator questions

What sponsor decision should this report or workflow support?
Is the blocker source quality, site execution, criteria friction, records, or scheduling capacity?
What changed since the last recruitment update?
Practical scenario

A useful sponsor review scenario

A sponsor reviews source movement and sees that one channel has volume but weak scheduled movement, while another is slower but produces stronger reviewable fit.

Before: the report shows totals without an action path.
After: the report separates source quality, site blockers, and next actions.

How teams usually use it

Compare it with the real queue

Read it next to the way your team already works. The gaps usually show up around ownership, missing records, follow-up timing, or sponsor-update prep.

Mark the handoffs

For each section, ask where the work changes hands. If the handoff depends on memory, a spreadsheet tab, or a buried message, that is probably worth fixing.

Keep the boundary clear

When the topic touches matching or prescreening, keep the language careful. Early fit is not enrollment, and final study decisions stay with authorized study teams.

Focused next reads for this topic

These links keep the page inside the same practical topic path instead of sending readers through broad navigation.

See it in TrialsNest

Turn this guide into a working recruitment workflow.

Walk through how patient intake, prescreening, records readiness, scheduling, and reporting connect in the product.

Do not start with more advertising

When a study under-enrolls, teams often jump to more advertising. That may be useful, but it is not a diagnosis. Under-enrollment can come from source quality, slow site follow-up, unclear eligibility, records blockers, visit burden, competing studies, or patient-facing language that sets the wrong expectations.

CTTI's Quality by Design approach emphasizes focusing on factors critical to trial quality and feasibility. A rescue plan should use the same discipline: identify the constraint before changing the tactic.

Use a rescue-plan framework

Compare planned versus actual inquiries by source, separate source volume from reviewable source quality, measure first-follow-up speed, review prescreen completion and abandonment, and track records blockers and scheduling blockers.

Then separate the decision points. A source-quality problem may need different targeting, a site-execution problem may need queue ownership, and a records-readiness problem may need earlier document review before more patients are added.

Teams should also review screen-failure reasons by site, assess whether protocol burden is realistic, and decide whether the fix belongs to the sponsor, site, source, or study design.

Case-study example

A sponsor increases ad spend after enrollment misses the forecast. Lead volume rises, but scheduled visits do not. The real issue is that patients are interested but records are not reviewed quickly enough, and coordinators are manually rebuilding status before sponsor calls.

The rescue action should focus on workflow and records readiness, not only advertising. Otherwise the team pays to push more patients into the same bottleneck and the sponsor sees more activity without more scheduled screening movement.

Build the rescue review cadence

A rescue plan needs a weekly operating cadence, not a one-time slide. The review should compare new inquiries, contacted patients, prescreen completion, records blockers, scheduling movement, screen failures, and close reasons by site.

Each metric should have an owner and a decision threshold. For example, slow first follow-up belongs to site operations, repeated records blockers may need document workflow repair, and high protocol-mismatch rates may need sponsor review.

Where TrialsNest fits

TrialsNest can support rescue planning by showing where patients stall across source quality, prescreen completion, coordinator follow-up, records readiness, scheduling movement, screen failure, and close reason categories.

That gives teams a practical operating view instead of another abstract funnel chart. A good rescue plan should end with owners, dates, decision thresholds, and the sponsor choices needed before the next enrollment update.

Sources used for this plan

CTTI Quality by Design recommendations support focusing rescue work on factors critical to trial quality and feasibility: https://www.ctti-clinicaltrials.org/wp-content/uploads/2020/01/ctti_quality_by_design_recommendations_final_1jun15_1.pdf

CTTI Critical to Quality factors help teams separate operating constraints from generic recruitment activity before changing tactics: https://ctti-clinicaltrials.org/about/ctti-projects/quality-by-design/qbd-quality-by-design-toolkit/exploring-the-critical-to-quality-ctq-factors/

NINDS recruitment and retention planning emphasizes realistic, targeted plans that are resourced, implemented, and adjusted over time: https://www.ninds.nih.gov/current-research/research-funded-ninds/clinical-research/recruitment-retention-planning-getting-started

Sponsor next step

Need cleaner recruitment visibility?

Review how TrialsNest packages lead flow, site activity, blockers, and next actions into sponsor-ready recruiting updates.

Related TrialsNest workflows

These resource pages connect back to the product areas buyers usually ask about: public study search, site recruitment workflow, sponsor visibility, and the privacy-aware operating model.

Trust Center

Topics covered

under enrolling clinical trial rescue planunder-enrolling clinical trialtrial recruitment rescue

Common questions

What should teams know about under enrolling clinical trial rescue plan?

Under-enrollment should be diagnosed before teams increase advertising spend. The constraint may be source quality, site follow-up, records blockers, eligibility ambiguity, visit burden, or sponsor decision lag. The practical value is in connecting the concept to ownership, follow-up, records readiness, scheduling, reporting, and clear next actions.

Who is this resource written for?

This resource is written for sponsors sorting through practical questions around under enrolling clinical trial rescue plan and the workflow decisions that usually come with it.

Does this guide replace study-team review or medical advice?

No. TrialsNest resources are educational and operational. They do not provide medical advice, diagnosis, treatment, emergency care, or final clinical trial eligibility decisions.

How would a team use this workflow guidance in practice?

Use it to compare the current workflow with what actually happens day to day: where leads wait, where records get lost, where follow-up slows down, and what needs a clearer owner. The best next step is to turn the article takeaways into a short review checklist for under enrolling clinical trial rescue plan.

Trust and proof points

Study-team decisions stay with authorized teams

TrialsNest can organize intake, prescreening, and workflow context, but it does not make final eligibility, enrollment, treatment, or medical decisions.

Reporting focuses on operational movement

Sponsor-ready updates should show source quality, movement, blockers, and next actions without becoming a broad patient-detail workspace.

Public pages stay educational

These resources explain clinical recruiting workflows and buying decisions. Sensitive study details belong in the appropriate secure workflow.

!
Heads up
Medical and eligibility decisions stay with the study team
TrialsNest does not provide medical advice, diagnosis, treatment, emergency care, or final study eligibility decisions. Authorized study teams review each protocol and applicant.

Continue exploring

Helpful next reads

Follow-up reading chosen from the same topic cluster and audience context as this guide.

Cookie preferences
Learn more about cookies

Essential cookies keep the site working. Optional cookies help improve traffic and regional insights.